Which has higher valuation and earnings, SIA or EXE?

Extendicare has higher revenue and earnings than Sienna Senior Living. Extendicare is trading at a lower price-to-earnings ratio than Sienna Senior Living, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sienna Senior Living C$1.08B 2.04 C$33.51M C$0.53 37.53 Extendicare C$1.98B 1.49 C$65.46M C$1.31 23.77

Does the media refer more to SIA or EXE?

In the previous week, Extendicare had 1 more articles in the media than Sienna Senior Living. MarketBeat recorded 2 mentions for Extendicare and 1 mentions for Sienna Senior Living. Extendicare's average media sentiment score of 0.55 beat Sienna Senior Living's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sienna Senior Living 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Extendicare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend EXE or DR?

Extendicare presently has a consensus price target of C$37.00, indicating a potential upside of 19.20%. Given Extendicare's stronger consensus rating and higher possible upside, equities analysts plainly believe Extendicare is more favorable than Medical Facilities. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Extendicare 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Medical Facilities 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, EXE or DR?

Extendicare has higher revenue and earnings than Medical Facilities. Medical Facilities is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Extendicare C$1.98B 1.49 C$65.46M C$1.31 23.77 Medical Facilities C$265.30M 0.94 C$17.17M C$1.88 8.22

Do analysts recommend EXE or CSH?

Extendicare presently has a consensus price target of C$37.00, suggesting a potential upside of 19.20%. Given Extendicare's stronger consensus rating and higher possible upside, analysts plainly believe Extendicare is more favorable than Chartwell Retirement Residences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Extendicare 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Chartwell Retirement Residences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has better valuation & earnings, EXE or CSH?

Extendicare has higher revenue and earnings than Chartwell Retirement Residences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Extendicare C$1.98B 1.49 C$65.46M C$1.31 23.77 Chartwell Retirement Residences N/A N/A N/A N/A N/A

Do analysts rate EHC or EXE?

Extendicare has a consensus target price of C$37.00, suggesting a potential upside of 19.20%. Given Extendicare's stronger consensus rating and higher possible upside, analysts plainly believe Extendicare is more favorable than Encompass Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Encompass Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Extendicare 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13

Which has higher earnings and valuation, EHC or EXE?

Extendicare has higher revenue and earnings than Encompass Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Encompass Health N/A N/A N/A N/A N/A Extendicare C$1.98B 1.49 C$65.46M C$1.31 23.77

Extendicare (EXE) Competitors

C$31.04 +0.03 (+0.10%)

As of 10:58 AM Eastern

Compare

EXE vs. CSH.UN, SIA, DR, CSH, and EHC

Should you buy Extendicare stock or one of its competitors? Extendicare's main competitors and comparable companies include Chartwell Retirement Residences (CSH.UN), Sienna Senior Living (SIA), Medical Facilities (DR), Chartwell Retirement Residences (CSH), and Encompass Health (EHC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare facilities" industry.

How does Extendicare compare to Chartwell Retirement Residences?

Chartwell Retirement Residences (TSE:CSH.UN) and Extendicare (TSE:EXE) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Chartwell Retirement Residences has a net margin of 17.92% compared to Extendicare's net margin of 6.13%. Extendicare's return on equity of 36.33% beat Chartwell Retirement Residences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chartwell Retirement Residences	17.92%	-4.61%	1.57%
Extendicare	6.13%	36.33%	7.16%

Chartwell Retirement Residences has a beta of 0.804628, indicating that its stock price is 20% less volatile than the broader market. Comparatively, Extendicare has a beta of 1.359619, indicating that its stock price is 36% more volatile than the broader market.

38.4% of Chartwell Retirement Residences shares are owned by institutional investors. Comparatively, 29.2% of Extendicare shares are owned by institutional investors. 0.6% of Chartwell Retirement Residences shares are owned by company insiders. Comparatively, 13.9% of Extendicare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Chartwell Retirement Residences presently has a consensus target price of C$25.77, indicating a potential upside of 27.08%. Extendicare has a consensus target price of C$37.00, indicating a potential upside of 19.20%. Given Chartwell Retirement Residences' higher possible upside, equities research analysts plainly believe Chartwell Retirement Residences is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chartwell Retirement Residences	0 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.10
Extendicare	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.13

Chartwell Retirement Residences pays an annual dividend of C$0.62 per share and has a dividend yield of 3.0%. Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.7%. Chartwell Retirement Residences pays out 3,327.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Extendicare pays out 39.2% of its earnings in the form of a dividend.

Extendicare has higher revenue and earnings than Chartwell Retirement Residences. Extendicare is trading at a lower price-to-earnings ratio than Chartwell Retirement Residences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chartwell Retirement Residences	C$1.21B	5.51	-C$40.86M	C$0.02	1,095.56
Extendicare	C$1.98B	1.49	C$65.46M	C$1.31	23.77

In the previous week, Extendicare had 2 more articles in the media than Chartwell Retirement Residences. MarketBeat recorded 2 mentions for Extendicare and 0 mentions for Chartwell Retirement Residences. Extendicare's average media sentiment score of 0.55 beat Chartwell Retirement Residences' score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company	Overall Sentiment
Chartwell Retirement Residences	Neutral
Extendicare	Positive

Summary

Extendicare beats Chartwell Retirement Residences on 11 of the 18 factors compared between the two stocks.

How does Extendicare compare to Sienna Senior Living?

Sienna Senior Living (TSE:SIA) and Extendicare (TSE:EXE) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

Sienna Senior Living presently has a consensus price target of C$26.45, indicating a potential upside of 33.00%. Extendicare has a consensus price target of C$37.00, indicating a potential upside of 19.20%. Given Sienna Senior Living's higher possible upside, equities research analysts plainly believe Sienna Senior Living is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sienna Senior Living	0 Sell rating(s)	0 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	3.09
Extendicare	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.13

Extendicare has higher revenue and earnings than Sienna Senior Living. Extendicare is trading at a lower price-to-earnings ratio than Sienna Senior Living, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sienna Senior Living	C$1.08B	2.04	C$33.51M	C$0.53	37.53
Extendicare	C$1.98B	1.49	C$65.46M	C$1.31	23.77

In the previous week, Extendicare had 1 more articles in the media than Sienna Senior Living. MarketBeat recorded 2 mentions for Extendicare and 1 mentions for Sienna Senior Living. Extendicare's average media sentiment score of 0.55 beat Sienna Senior Living's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sienna Senior Living	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Extendicare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sienna Senior Living pays an annual dividend of C$0.94 per share and has a dividend yield of 4.7%. Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.7%. Sienna Senior Living pays out 176.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Extendicare pays out 39.2% of its earnings in the form of a dividend.

Sienna Senior Living has a beta of 1.036964, meaning that its share price is 4% more volatile than the broader market. Comparatively, Extendicare has a beta of 1.359619, meaning that its share price is 36% more volatile than the broader market.

Extendicare has a net margin of 6.13% compared to Sienna Senior Living's net margin of 4.83%. Extendicare's return on equity of 36.33% beat Sienna Senior Living's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sienna Senior Living	4.83%	6.58%	3.58%
Extendicare	6.13%	36.33%	7.16%

29.6% of Sienna Senior Living shares are held by institutional investors. Comparatively, 29.2% of Extendicare shares are held by institutional investors. 0.1% of Sienna Senior Living shares are held by company insiders. Comparatively, 13.9% of Extendicare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Extendicare beats Sienna Senior Living on 12 of the 18 factors compared between the two stocks.

How does Extendicare compare to Medical Facilities?

Extendicare (TSE:EXE) and Medical Facilities (TSE:DR) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Extendicare presently has a consensus price target of C$37.00, indicating a potential upside of 19.20%. Given Extendicare's stronger consensus rating and higher possible upside, equities analysts plainly believe Extendicare is more favorable than Medical Facilities.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Extendicare	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.13
Medical Facilities	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Extendicare had 2 more articles in the media than Medical Facilities. MarketBeat recorded 2 mentions for Extendicare and 0 mentions for Medical Facilities. Extendicare's average media sentiment score of 0.55 beat Medical Facilities' score of 0.00 indicating that Extendicare is being referred to more favorably in the media.

Company	Overall Sentiment
Extendicare	Positive
Medical Facilities	Neutral

Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.7%. Medical Facilities pays an annual dividend of C$0.26 per share and has a dividend yield of 1.7%. Extendicare pays out 39.2% of its earnings in the form of a dividend. Medical Facilities pays out 13.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Medical Facilities is clearly the better dividend stock, given its higher yield and lower payout ratio.

Extendicare has a beta of 1.359619, suggesting that its share price is 36% more volatile than the broader market. Comparatively, Medical Facilities has a beta of 0.497169, suggesting that its share price is 50% less volatile than the broader market.

29.2% of Extendicare shares are held by institutional investors. Comparatively, 15.3% of Medical Facilities shares are held by institutional investors. 13.9% of Extendicare shares are held by insiders. Comparatively, 0.4% of Medical Facilities shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Extendicare has higher revenue and earnings than Medical Facilities. Medical Facilities is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Extendicare	C$1.98B	1.49	C$65.46M	C$1.31	23.77
Medical Facilities	C$265.30M	0.94	C$17.17M	C$1.88	8.22

Medical Facilities has a net margin of 13.87% compared to Extendicare's net margin of 6.13%. Medical Facilities' return on equity of 45.36% beat Extendicare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Extendicare	6.13%	36.33%	7.16%
Medical Facilities	13.87%	45.36%	13.60%

Summary

Extendicare beats Medical Facilities on 13 of the 19 factors compared between the two stocks.

How does Extendicare compare to Chartwell Retirement Residences?

Extendicare (TSE:EXE) and Chartwell Retirement Residences (TSE:CSH) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations.

29.2% of Extendicare shares are owned by institutional investors. 13.9% of Extendicare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company	Overall Sentiment
Extendicare	Positive
Chartwell Retirement Residences	Neutral

Extendicare presently has a consensus price target of C$37.00, suggesting a potential upside of 19.20%. Given Extendicare's stronger consensus rating and higher possible upside, analysts plainly believe Extendicare is more favorable than Chartwell Retirement Residences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Extendicare	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.13
Chartwell Retirement Residences	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Extendicare has higher revenue and earnings than Chartwell Retirement Residences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Extendicare	C$1.98B	1.49	C$65.46M	C$1.31	23.77
Chartwell Retirement Residences	N/A	N/A	N/A	N/A	N/A

Extendicare has a net margin of 6.13% compared to Chartwell Retirement Residences' net margin of 0.00%. Extendicare's return on equity of 36.33% beat Chartwell Retirement Residences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Extendicare	6.13%	36.33%	7.16%
Chartwell Retirement Residences	N/A	N/A	N/A

Summary

Extendicare beats Chartwell Retirement Residences on 12 of the 12 factors compared between the two stocks.

How does Extendicare compare to Encompass Health?

Encompass Health (CNSX:EHC) and Extendicare (TSE:EXE) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and risk.

Extendicare has a net margin of 6.13% compared to Encompass Health's net margin of 0.00%. Extendicare's return on equity of 36.33% beat Encompass Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Encompass Health	N/A	N/A	N/A
Extendicare	6.13%	36.33%	7.16%

Extendicare has higher revenue and earnings than Encompass Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Encompass Health	N/A	N/A	N/A	N/A	N/A
Extendicare	C$1.98B	1.49	C$65.46M	C$1.31	23.77

29.2% of Extendicare shares are held by institutional investors. 13.9% of Extendicare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Extendicare has a consensus target price of C$37.00, suggesting a potential upside of 19.20%. Given Extendicare's stronger consensus rating and higher possible upside, analysts plainly believe Extendicare is more favorable than Encompass Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Encompass Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Extendicare	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.13

In the previous week, Extendicare had 2 more articles in the media than Encompass Health. MarketBeat recorded 2 mentions for Extendicare and 0 mentions for Encompass Health. Extendicare's average media sentiment score of 0.55 beat Encompass Health's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company	Overall Sentiment
Encompass Health	Neutral
Extendicare	Positive

Summary

Extendicare beats Encompass Health on 12 of the 12 factors compared between the two stocks.

Get Extendicare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EXE vs. The Competition

Export

Metric	Extendicare	Healthcare Providers & Services Industry	Healthcare Sector	TSE Exchange
Market Cap	C$2.95B	C$9.94B	C$7.20B	C$12.58B
Dividend Yield	1.71%	2.61%	2.57%	6.28%
P/E Ratio	23.77	34.02	275.02	39.47
Price / Sales	1.49	4.98	638.08	9.29
Price / Cash	3.20	24.78	28.42	82.29
Price / Book	7.32	5.36	10.32	4.62
Net Income	C$65.46M	C$313.45M	C$3.50B	C$299.09M
7 Day Performance	-0.19%	-0.58%	-2.41%	-1.81%
1 Month Performance	-5.19%	-0.84%	0.22%	-1.89%
1 Year Performance	133.73%	58.31%	24.17%	22.68%

Extendicare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EXE Extendicare	3.2695 of 5 stars	C$31.04 +0.1%	C$37.00 +19.2%	+133.5%	C$2.95B	C$1.98B	23.77	23,500
CSH.UN Chartwell Retirement Residences	N/A	C$20.81 flat	C$25.77 +23.8%	+4.8%	C$6.83B	C$1.21B	1,124.20	11,452
SIA Sienna Senior Living	2.9979 of 5 stars	C$20.29 flat	C$26.45 +30.4%	+8.7%	C$2.25B	C$1.08B	38.28	12,000
DR Medical Facilities	N/A	C$15.21 flat	N/A	+3.6%	C$246.60M	C$265.30M	8.09	1,833	High Trading Volume
CSH Chartwell Retirement Residences	N/A	N/A	N/A	N/A	C$0.00	N/A	N/A	N/A	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:EXE) was last updated on 9/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Extendicare (EXE) Competitors

EXE vs. CSH.UN, SIA, DR, CSH, and EHC

How does Extendicare compare to Chartwell Retirement Residences?

Summary

How does Extendicare compare to Sienna Senior Living?

Summary

How does Extendicare compare to Medical Facilities?

Summary

How does Extendicare compare to Chartwell Retirement Residences?

Summary

How does Extendicare compare to Encompass Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EXE vs. The Competition

Extendicare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Extendicare (EXE) Competitors

EXE vs. CSH.UN, SIA, DR, CSH, and EHC

How does Extendicare compare to Chartwell Retirement Residences?

Is CSH.UN or EXE more profitable?

Which has more risk and volatility, CSH.UN or EXE?

Do institutionals & insiders believe in CSH.UN or EXE?

Do analysts prefer CSH.UN or EXE?

Is CSH.UN or EXE a better dividend stock?

Which has preferable valuation and earnings, CSH.UN or EXE?

Does the media prefer CSH.UN or EXE?

Summary

How does Extendicare compare to Sienna Senior Living?

Do analysts recommend SIA or EXE?

Which has higher valuation and earnings, SIA or EXE?

Does the media refer more to SIA or EXE?

Is SIA or EXE a better dividend stock?

Which has more volatility and risk, SIA or EXE?

Is SIA or EXE more profitable?

Do institutionals & insiders have more ownership in SIA or EXE?

Summary

How does Extendicare compare to Medical Facilities?

Do analysts recommend EXE or DR?

Does the media prefer EXE or DR?

Is EXE or DR a better dividend stock?

Which has more volatility & risk, EXE or DR?

Do insiders and institutionals believe in EXE or DR?

Which has higher valuation and earnings, EXE or DR?

Is EXE or DR more profitable?

Summary

How does Extendicare compare to Chartwell Retirement Residences?

Do insiders & institutionals have more ownership in EXE or CSH?

Does the media refer more to EXE or CSH?

Do analysts recommend EXE or CSH?

Which has better valuation & earnings, EXE or CSH?

Is EXE or CSH more profitable?

Summary

How does Extendicare compare to Encompass Health?

Is EHC or EXE more profitable?

Which has higher earnings and valuation, EHC or EXE?

Do institutionals & insiders hold more shares of EHC or EXE?

Do analysts rate EHC or EXE?

Does the media refer more to EHC or EXE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EXE vs. The Competition

Extendicare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools